Architecture, Engineering and Construction Leaders to Participate in BuildingsNY 2018

BuildingsNY 2018 is just around the corner, and this year’s event is shaping up to make a pre-summer splash on May 8 and 9 at the Javits Center in Manhattan. The show features a full product life-cycle solution for safe and cost-effective building operations by integrating exhibitions, free accredited education, partnership opportunities, and networking events.

In a unique effort to bring City Hall to consumers, the New York City Department of Buildings and Finance will be on hand to provide interactive education sessions and a chance to participate in their clinic. Other educational sessions will delve into various topics, such as understanding the conditions of a construction contract, using cloud-based intelligence to meet greenhouse standards, overcoming vacancy issues, and many more!

This year’s vendor list represents industry leadership in energy-saving solutions. Some notable exhibitors include Meridian Capital Group, Wirecrafters LLC, and East Coast Lighting, among many others. Attendees will have a chance to vote once a day for the most creative booth design and the best use of innovation. Wining exhibitors will receive $1,000 in credits toward sponsorship options at future shows, as well as PR and social coverage at their booth. Also, every day, one voter will win a $100 American Express gift card.

With over 45,000-square-feet of exhibition floor, a variety of topics, and a wealth of information presented by industry leaders, BuidlingsNY aims to foster growth, share knowledge, and create camaraderie among professionals at every level.

To learn more, visit BuildingsNY online.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More